OMEROS CORP

OMER · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.1B · 175 employees
301
SEC Filings
$20.08
Close 2026-09-25
175
Employees

Business Summary

Omeros Corporation is a commercial-stage biotechnology company developing first-in-class protein and small-molecule therapeutics for complement-mediated diseases, cancers, and addictive disorders. Its FDA-approved product YARTEMLEA (narsoplimab-wuug) treats TA-TMA, a stem cell transplant complication. The company also partners with Novo Nordisk on zaltenibart (MASP-3 inhibitor) and maintains a pipeline including OMS1029, OMS527, and several preclinical programs.

Latest Stock Quote

OMER 2026-09-25 $20.08 O:$20.39 H:$20.61 L:$19.66 Vol:0.9M VWAP:$20.0912
origin leaf: null

Next Earnings

expected 2026-11-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001437749-26-010636EDGAR68K words
2025-03-312024-12-310001437749-25-010216EDGAR64K words
2024-04-012023-12-310001437749-24-010416EDGAR57K words
2023-03-132022-12-310001558370-23-003575EDGAR60K words
2022-03-012021-12-310001558370-22-002582EDGAR—
2021-03-012020-12-310001558370-21-002177EDGAR—
2020-03-022019-12-310001558370-20-001891EDGAR—
2019-03-012018-12-310001628280-19-002324EDGAR—
2018-03-012017-12-310001285819-18-000003EDGAR—
2017-03-162016-12-310001285819-17-000004EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001437749-26-027318EDGAR30K words
2025-11-132025-09-300001437749-25-034826EDGAR30K words
2025-08-142025-06-300001437749-25-026933EDGAR30K words
2025-05-152025-03-310001437749-25-017213EDGAR22K words
2024-11-132024-09-300001437749-24-034903EDGAR27K words
2024-08-072024-06-300001437749-24-025181EDGAR25K words
2024-05-152024-03-310001437749-24-017047EDGAR19K words
2023-11-092023-09-300001437749-23-031250EDGAR22K words
2023-08-092023-06-300001558370-23-014095EDGAR17K words
2023-05-092023-03-310001558370-23-008814EDGAR16K words
2022-11-092022-09-300001558370-22-017153EDGAR20K words
2022-08-092022-06-300001558370-22-012884EDGAR18K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-130001552781-26-000441EDGAR1K words
2026-08-120001437749-26-027313EDGAR5K words
2026-07-200001437749-26-023886EDGAR1K words
2026-03-310001437749-26-010634EDGAR5K words
2026-01-070001437749-26-000820EDGAR1K words
2025-12-290001437749-25-038758EDGAR3K words
2025-12-010001437749-25-036507EDGAR4K words
2025-11-130001437749-25-034824EDGAR6K words
2025-10-150001437749-25-030968EDGAR2K words
2025-08-140001437749-25-026931EDGAR4K words

301 total filings indexed. 269 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

complement-mediated-diseases hematopoietic-stem-cell-transplant-complications-(ta-tma) paroxysmal-nocturnal-hemoglobinuria-(pnh) renal-diseases-(igan,-c3-glomerulopathy,-ahus) acute-respiratory-distress-syndrome-(ards) addictive-and-compulsive-disorders oncology-(acute-myeloid-leukemia) orphan-indications

Company Identity

CIK0001285819
TickerOMER
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedWA
Websitehttps://www.omeros.com
Listed2009-10-08

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: a27adfc62598517c4ef8550edd8204d0e671999ff74000f4e4c9a8ed30bb4ec9
parent: 3d79db710c8a5d576e655326fdaacb0ef976ef93d0433f0c0f0f5df8b9ee3322
content hash: 62b5a540bba331f48c863d8822ea8e89e882c6eeb2d72068b730b857539cdb03
signed: 2026-09-30T19:02:42.525Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up OMER using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on OMER, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/OMER (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.